Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.

by Yi-Chieh Nancy Du, David S Klimstra, Harold Varmus
Published 2009-09-01

p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells

by Stephanie Azzopardi, Sharon Pang, David S. Klimstra, Yi-Chieh Nancy Du
Published 2016-10-01

The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.

by Leanne G Ahronian, David R Driscoll, David S Klimstra, Brian C Lewis
Published 2015-01-01

Esophageal adenocarcinoma and squamous cell carcinoma in children and adolescents: Report of 3 cases and comprehensive literature review

by Till M. Theilen, Alexander J. Chou, David S. Klimstra, Michael P. LaQuaglia
Published 2016-02-01

STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.

by Atsushi Tanaka, Yihua Zhou, Makiko Ogawa, Jinru Shia, David S Klimstra, Julia Y Wang, Michael H Roehrl
Published 2020-01-01

DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability

by Atsushi Tanaka, Julia Y. Wang, Jinru Shia, Yihua Zhou, Makiko Ogawa, Ronald C. Hendrickson, David S. Klimstra, Michael H. Roehrl
Published 2020-12-01

p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells.

by Ya-Wen Chen, Hsiao-Chien Chu, Ze-Shiang Lin, Wei-Jyh Shiah, Chen-Pin Chou, David S Klimstra, Brian C Lewis
Published 2013-01-01

(Re) Defining the high-power field for digital pathology

by David Kim, Liron Pantanowitz, Peter Schüffler, Dig Vijay Kumar Yarlagadda, Orly Ardon, Victor E Reuter, Meera Hameed, David S Klimstra, Matthew G Hanna
Published 2020-01-01

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.

by Jian Zheng, Eran Sadot, Joana A Vigidal, David S Klimstra, Vinod P Balachandran, T Peter Kingham, Peter J Allen, Michael I D'Angelica, Ronald P DeMatteo, William R Jarnagin, Andrea Ventura
Published 2018-01-01

Validation of mitotic cell quantification via microscopy and multiple whole-slide scanners

by Kazuhiro Tabata, Naohiro Uraoka, Jamal Benhamida, Matthew G. Hanna, Sahussapont Joseph Sirintrapun, Brandon D. Gallas, Qi Gong, Rania G. Aly, Katsura Emoto, Kant M. Matsuda, Meera R. Hameed, David S. Klimstra, Yukako Yagi
Published 2019-06-01

Maspin as a Prognostic Marker for Early Stage Colorectal Cancer With Microsatellite Instability

by Atsushi Tanaka, Atsushi Tanaka, Atsushi Tanaka, Julia Y. Wang, Jinru Shia, Yihua Zhou, Yihua Zhou, Makiko Ogawa, Makiko Ogawa, Ronald C. Hendrickson, David S. Klimstra, Michael H. A. Roehrl, Michael H. A. Roehrl
Published 2020-06-01

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

by Chang S. Chan, Saurabh V. Laddha, Peter W. Lewis, Matthew S. Koletsky, Kenneth Robzyk, Edaise Da Silva, Paula J. Torres, Brian R. Untch, Janet Li, Promita Bose, Timothy A. Chan, David S. Klimstra, C. David Allis, Laura H. Tang
Published 2018-10-01

Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.

by Eric C Sorenson, Raya Khanin, Zubin M Bamboat, Michael J Cavnar, Teresa S Kim, Eran Sadot, Shan Zeng, Jonathan B Greer, Adrian M Seifert, Noah A Cohen, Noah A Cohen, Megan H Crawley, Benjamin L Green, David S Klimstra, Ronald P DeMatteo
Published 2017-01-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

by Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen
Published 2012-01-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers.

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01

Digital Pathology Operations at an NYC Tertiary Cancer Center During the First 4 Months of COVID-19 Pandemic Response

by Orly Ardon PhD, MBA, Victor E. Reuter MD, Meera Hameed MD, Lorraine Corsale BFA, Allyne Manzo BFA, Sahussapont J. Sirintrapun MD, Peter Ntiamoah PhD, Evangelos Stamelos MS, Peter J. Schueffler PhD, Christine England MBA, David S. Klimstra MD, Matthew G. Hanna MD
Published 2021-04-01